Abstract
The prognosis for patients with rheumatoid arthritis has improved dramatically, thanks in large part to many new therapies and therapeutic approaches. Paradoxically, this has created problems for rheumatologists since clinically useful information from appropriate clinical trials has not kept pace with all the new therapeutic options. Essentially, rheumatologists now have many more therapeutic options than they know what to do with. This article discusses why we are in this situation and suggests opportunities to move forward.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 457-461 |
| Number of pages | 5 |
| Journal | Best Practice and Research: Clinical Rheumatology |
| Volume | 24 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2010 |
Keywords
- clinical trials
- comparative effectiveness research
- ethics
- rheumatoid arthritis
ASJC Scopus subject areas
- Rheumatology